Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 3.62 -2.43% -0.09
MRNS closed down 2.43 percent on Friday, December 14, 2018, on 1.56 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical MRNS trend table...

Date Alert Name Type % Chg
Dec 14 MACD Bearish Signal Line Cross Bearish 0.00%
Dec 14 Calm After Storm Range Contraction 0.00%
Dec 14 Narrow Range Bar Range Contraction 0.00%
Dec 14 NR7 Range Contraction 0.00%
Dec 14 Lower Bollinger Band Walk Weakness 0.00%
Dec 14 Stochastic Reached Oversold Weakness 0.00%
Dec 14 Inside Day Range Contraction 0.00%
Dec 14 Wide Bands Range Expansion 0.00%
Dec 14 Down 3 Days in a Row Weakness 0.00%
Dec 14 Down 4 Days in a Row Weakness 0.00%

Older signals for MRNS ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Is MRNS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.54
52 Week Low 3.31
Average Volume 1,279,900
200-Day Moving Average 5.879
50-Day Moving Average 5.2698
20-Day Moving Average 4.506
10-Day Moving Average 4.647
Average True Range 0.5423
ADX 20.92
+DI 18.3683
-DI 28.346
Chandelier Exit (Long, 3 ATRs ) 4.3731
Chandelier Exit (Short, 3 ATRs ) 4.9969
Upper Bollinger Band 5.4107
Lower Bollinger Band 3.6013
Percent B (%b) 0.01
BandWidth 40.155348
MACD Line -0.2734
MACD Signal Line -0.2352
MACD Histogram -0.0382
Fundamentals Value
Market Cap 94.39 Million
Num Shares 26.1 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -3.29
Price-to-Sales 0.00
Price-to-Book 7.28
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.98
Resistance 3 (R3) 4.01 3.92 3.92
Resistance 2 (R2) 3.92 3.83 3.91 3.90
Resistance 1 (R1) 3.77 3.77 3.85 3.74 3.88
Pivot Point 3.68 3.68 3.72 3.67 3.68
Support 1 (S1) 3.53 3.59 3.61 3.50 3.36
Support 2 (S2) 3.44 3.53 3.43 3.34
Support 3 (S3) 3.29 3.44 3.32
Support 4 (S4) 3.26